Development of a cost-effective 'duplexed' real-time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes

Int J Lab Hematol. 2016 Dec;38(6):e102-e106. doi: 10.1111/ijlh.12541. Epub 2016 Jul 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Neoplasm, Residual / diagnosis
  • Nucleic Acid Probes
  • Oligonucleotides*
  • Real-Time Polymerase Chain Reaction / economics
  • Real-Time Polymerase Chain Reaction / methods*

Substances

  • Nucleic Acid Probes
  • Oligonucleotides
  • locked nucleic acid